← All trials
NCT00884663
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 1, 2009
- Primary completion
- Mar 1, 2012
- Completion date
- Mar 1, 2012
- First posted
- —
- Last posted
- —
- Enrollment
- 72
- Arms / groups
- 3 / —
- Source
- AACT · pre-existing
Sponsors
- Norwegian University of Science and TechnologyLead sponsor
- Norwegian University of Science and TechnologyOverall official - principal investigator
- Norwegian National Headache CentreStudy director
- AstraZenecaCollaborator
- Norwegian University of Science and TechnologyCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.